WI
Windtree Therapeutics, Inc.
WINT · OTC
$0.00 -33.33% (-$0.00)
1M +100.00%
Market Cap $10.1K
P/E Ratio -
Div. Yield -
ROE 1,302.82%
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.11x
EV/FFO N/A
P/E N/A
Growth
0 /100
Declining Book val. growth 37.97%
FCF growth N/A
EPS growth N/A
Profitability
0 /100
Weak Op. margin 37,218.90%
Gross margin 387.78%
FCF margin 16,801.10%
Quality
0 /100
Poor ROA 250.29%
ROIC 455.49%
Asset turnover 0.01x
Debt
0 /100
High Int. coverage -88.14x
Current ratio 0.33x
Debt/Assets N/A
Stability
44 /100
Moderate Profitable years 0
Beta 1.60x
EPS volatility 23.45%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na WINT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jed A. Latkin
Employees
14
Headquarters
Warrington
Nadcházející události
26 LIS
Earnings
Upcoming earnings report